Polymorphids an mRNA Expression in Obese Genes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01708083|
Recruitment Status : Completed
First Posted : October 16, 2012
Last Update Posted : August 22, 2013
Fat tissue from omenta, thigh and abdomen taken under anesthesia on subjects undergoing laparoscopic surgery, cholecystectomy, reflux surgery or gastric by-pass (GBP).
Are there any difference in polymorphids and/or mRNA expression in genes significant for developing obesity, between normal weight and obese individuals, with or without diabetes typ 2 .
Are there any difference in polymorphids and/or mRNA expression in different types of fat tissue
|Condition or disease|
|Polymorphism mRNA Expression|
|Study Type :||Observational|
|Actual Enrollment :||50 participants|
|Official Title:||Polymorphids and mRNA Expression in Genes, Significant for Developing Obesity and Typ II Diabetes in Different Types/Localisations of Fat Tissue|
|Study Start Date :||January 2010|
|Actual Primary Completion Date :||February 2013|
|Actual Study Completion Date :||February 2013|
Type 2 Diabetes and BMI>35
Patients with type 2 diabetes and body mass index 35 or more.
Patients undergoing surgery, gastric bypass or cholecystectomy, without diabetes type 2 and body mass index 35 or more
Patients undergoing surgery, cholecystectomy or reflux, without type 2 diabetes and body mass index between 18-27
- Differences in polymorphids and/or mRNA expression in genes, significant for developing obesity and type 2 diabetes, between patients with normal weight and obesity [ Time Frame: approximatly 30 minutes after start of operation ]fat biopsy taken from abdomen, omenta and thigh at surgery
- Difference in polymorphids and/or mRNA expression in different types of fat tissue in patients with normal weight or obesity with or without diabetes type 2 [ Time Frame: approximatly 30 minutes after start of operation ]fat biopsy; abdomen, omenta and thigh taken at surgery
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01708083
|Stockholm, Stockholm County Council, Sweden, 116 91|
|Karolinska Institutet, CMM|
|Stockholm, Sweden, 171 76|
|Principal Investigator:||Anders Thorell, Ass. prof.||Karolinska Institutet|